Richard E Uihlein - Net Worth and Insider Trading

Richard E Uihlein Net Worth

The estimated net worth of Richard E Uihlein is at least $24 Million dollars as of 2024-05-12. Richard E Uihlein is the Director, 10% Owner of Galectin Therapeutics Inc and owns about 7,920,901 shares of Galectin Therapeutics Inc (GALT) stock worth over $24 Million. Details can be seen in Richard E Uihlein's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Richard E Uihlein has not made any transactions after 2020-09-04 and currently still holds the listed stock(s).

Transaction Summary of Richard E Uihlein

To

Richard E Uihlein Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Richard E Uihlein owns 1 companies in total, including Galectin Therapeutics Inc (GALT) .

Click here to see the complete history of Richard E Uihlein’s form 4 insider trades.

Insider Ownership Summary of Richard E Uihlein

Ticker Comapny Transaction Date Type of Owner
GALT Galectin Therapeutics Inc 2020-09-04 director & 10 percent owner

Richard E Uihlein Latest Holdings Summary

Richard E Uihlein currently owns a total of 1 stock. Richard E Uihlein owns 7,920,901 shares of Galectin Therapeutics Inc (GALT) as of September 4, 2020, with a value of $24 Million.

Latest Holdings of Richard E Uihlein

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
GALT Galectin Therapeutics Inc 2020-09-04 7,920,901 3.03 24,000,330

Holding Weightings of Richard E Uihlein


Richard E Uihlein Form 4 Trading Tracker

According to the SEC Form 4 filings, Richard E Uihlein has made a total of 3 transactions in Galectin Therapeutics Inc (GALT) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Galectin Therapeutics Inc is the acquisition of 10,000 shares on September 4, 2020, which cost Richard E Uihlein around $25,500.

Insider Trading History of Richard E Uihlein

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Richard E Uihlein Trading Performance

GuruFocus tracks the stock performance after each of Richard E Uihlein's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Richard E Uihlein is -11.93%. GuruFocus also compares Richard E Uihlein's trading performance to market benchmark return within the same time period. The performance of stocks bought by Richard E Uihlein within 3 months outperforms 0 times out of 7 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Richard E Uihlein's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Richard E Uihlein

Average Return

Average return per transaction

Outperforming Transactions

1 out of 7 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 0.32
Relative Return to S&P 500(%) -3.55

Richard E Uihlein Ownership Network

Ownership Network List of Richard E Uihlein

No Data

Ownership Network Relation of Richard E Uihlein


Richard E Uihlein Owned Company Details

What does Galectin Therapeutics Inc do?

Who are the key executives at Galectin Therapeutics Inc?

Richard E Uihlein is the director & 10 percent owner of Galectin Therapeutics Inc. Other key executives at Galectin Therapeutics Inc include 10 percent owner 10x Fund, L.p. , Chief Medical Officer Pol F Boudes , and Chief Financial Officer Jack W Callicutt .

Galectin Therapeutics Inc (GALT) Insider Trades Summary

Over the past 18 months, Richard E Uihlein made no insider transaction in Galectin Therapeutics Inc (GALT). Other recent insider transactions involving Galectin Therapeutics Inc (GALT) include a net purchase of 3,398 shares made by Kary Eldred , a net sale of 25,000 shares made by James C Czirr , and a net purchase of 2,500 shares made by Kevin D Freeman .

In summary, during the past 3 months, insiders sold 25,000 shares of Galectin Therapeutics Inc (GALT) in total and bought 4,500 shares, with a net sale of 20,500 shares. During the past 18 months, 25,000 shares of Galectin Therapeutics Inc (GALT) were sold and 7,898 shares were bought by its insiders, resulting in a net sale of 17,102 shares.

Galectin Therapeutics Inc (GALT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Galectin Therapeutics Inc Insider Transactions

No Available Data

Richard E Uihlein Mailing Address

Above is the net worth, insider trading, and ownership report for Richard E Uihlein. You might contact Richard E Uihlein via mailing address: 12575 Uline Drive, Pleasant Prairie Wi 53158.

Discussions on Richard E Uihlein

No discussions yet.